BCL-16539-37097
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 100 / NY
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-06
Registered in v-safe
- 2021-04-23
-
2021-06-14
Survey response — 3 months, dose 1MedDRA: Chest pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-12
-
2021-12-19
Dose 2 — Moderna
- 2022-03-12
- 2022-03-20
-
2022-12-19
Dose 3 — Moderna
- 2022-12-21
-
2022-12-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-19 | Moderna | No |
| 3 | 2022-12-19 | Moderna | No |
Free text
Release 9 — 3 months, dose 1
Symptoms: Chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release